Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6854586rdf:typepubmed:Citationlld:pubmed
pubmed-article:6854586lifeskim:mentionsumls-concept:C0010815lld:lifeskim
pubmed-article:6854586lifeskim:mentionsumls-concept:C0597358lld:lifeskim
pubmed-article:6854586lifeskim:mentionsumls-concept:C0682770lld:lifeskim
pubmed-article:6854586lifeskim:mentionsumls-concept:C0392762lld:lifeskim
pubmed-article:6854586lifeskim:mentionsumls-concept:C1879746lld:lifeskim
pubmed-article:6854586lifeskim:mentionsumls-concept:C1547011lld:lifeskim
pubmed-article:6854586pubmed:issue6lld:pubmed
pubmed-article:6854586pubmed:dateCreated1983-7-8lld:pubmed
pubmed-article:6854586pubmed:abstractTextCongeneric 4-anilino- and 4-(alkylamino)-2-methylpyrrolo[2,3-d]pyrimidines showed cytokinin and anticytokinin activities, depending on the structure of their 4-substituents, and the antagonistic nature of the latter was established kinetically. The effect of the substituent on these activities was analyzed quantitatively by using physicochemical parameters and regression analysis to give a single, common equation for both the agonists and antagonists. The results indicated that the maximum width of the N4 substituents is an important factor both for binding to the receptor, thus the extent of activity, and for the quality of activity, agonistic or antagonistic. The electron-withdrawing effect and hydrophobicity of the substituents further enhance binding and, thus, activity, irrespective of the quality of the activity. These results coincide with and/or provide evidence for the hypothesis that in hormonal action, agonist binding causes a conformational change of an otherwise inactive receptor to the active form and that antagonists are species that bind similarly to the receptor but do not cause the effective conformational change.lld:pubmed
pubmed-article:6854586pubmed:languageenglld:pubmed
pubmed-article:6854586pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6854586pubmed:citationSubsetIMlld:pubmed
pubmed-article:6854586pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6854586pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6854586pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6854586pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6854586pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6854586pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6854586pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6854586pubmed:statusMEDLINElld:pubmed
pubmed-article:6854586pubmed:monthJunlld:pubmed
pubmed-article:6854586pubmed:issn0022-2623lld:pubmed
pubmed-article:6854586pubmed:authorpubmed-author:MatsubaraSSlld:pubmed
pubmed-article:6854586pubmed:authorpubmed-author:MasudaNNlld:pubmed
pubmed-article:6854586pubmed:authorpubmed-author:KoshimizuKKlld:pubmed
pubmed-article:6854586pubmed:authorpubmed-author:IwamuraHHlld:pubmed
pubmed-article:6854586pubmed:issnTypePrintlld:pubmed
pubmed-article:6854586pubmed:volume26lld:pubmed
pubmed-article:6854586pubmed:ownerNLMlld:pubmed
pubmed-article:6854586pubmed:authorsCompleteYlld:pubmed
pubmed-article:6854586pubmed:pagination838-44lld:pubmed
pubmed-article:6854586pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:6854586pubmed:meshHeadingpubmed-meshheading:6854586-...lld:pubmed
pubmed-article:6854586pubmed:meshHeadingpubmed-meshheading:6854586-...lld:pubmed
pubmed-article:6854586pubmed:meshHeadingpubmed-meshheading:6854586-...lld:pubmed
pubmed-article:6854586pubmed:meshHeadingpubmed-meshheading:6854586-...lld:pubmed
pubmed-article:6854586pubmed:meshHeadingpubmed-meshheading:6854586-...lld:pubmed
pubmed-article:6854586pubmed:meshHeadingpubmed-meshheading:6854586-...lld:pubmed
pubmed-article:6854586pubmed:meshHeadingpubmed-meshheading:6854586-...lld:pubmed
pubmed-article:6854586pubmed:meshHeadingpubmed-meshheading:6854586-...lld:pubmed
pubmed-article:6854586pubmed:meshHeadingpubmed-meshheading:6854586-...lld:pubmed
pubmed-article:6854586pubmed:meshHeadingpubmed-meshheading:6854586-...lld:pubmed
pubmed-article:6854586pubmed:year1983lld:pubmed
pubmed-article:6854586pubmed:articleTitleQuantitative aspects of the receptor binding of cytokinin agonists and antagonists.lld:pubmed
pubmed-article:6854586pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6854586pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:6854586lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6854586lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6854586lld:pubmed